期刊文献+
共找到190篇文章
< 1 2 10 >
每页显示 20 50 100
Duodenum and ventral pancreas preserving subtotal pancreatectomy for low-grade malignant neoplasms of the pancreas: An alternative procedure to total pancreatectomy for low-grade pancreatic neoplasms 被引量:2
1
作者 Xing Wang Chun-Lu Tan +2 位作者 Hai-Yu Song Qiang Yao Xu-Bao Liu 《World Journal of Gastroenterology》 SCIE CAS 2017年第35期6457-6466,共10页
AIM To describe the indications, technique and outcomes of the novel surgical procedure of duodenum and ventral pancreas preserving subtotal pancreatectomy(DVPPSP).METHODS Data collected retrospectively from 43 patien... AIM To describe the indications, technique and outcomes of the novel surgical procedure of duodenum and ventral pancreas preserving subtotal pancreatectomy(DVPPSP).METHODS Data collected retrospectively from 43 patients who underwent DVPPSP and TP between 2009 and 2015 in our single centre were analysed. For enrolment, only patients with low-grade pancreatic neoplasms, such as pancreatic neuroendocrine tumors, intraductal papillary mucinous neoplasms(IPMNs), and solid pseudopapillary tumors, were included. Ten DVPPSP(group 1) and 13 TP(group 2) patients were selected in this study.RESULTS There were no significant differences in age, gender, comorbidities, preoperative symptoms, American Society of Anesthesiologists score or indications for surgery between the two groups. The most common indication was IPMN for DVPPSP and TP(60% vs 85%, P = 0.411). Compared with the TP group, the DVPPSP group had comparable postoperative morbidities(P = 0.405) and mortalities(both nil), but significantly shorter operative time(232 ± 19.6 min vs 335 ± 32.3 min, P < 0.001). DVPPSP preserved better long-term pancreatic function with less supplementary therapy(P < 0.001) and better quality of life(Qo L) after surgery, including better scores in social(P = 0.042) and global health(P = 0.047) on functional scales and less appetite loss(P = 0.049) on the symptom scale. CONCLUSION DVPPSP is a feasible and safe procedure that could be an alternative to TP for low-grade neoplasms arising from the body and tail region but across the neck region of the pancreas; DVPPSP had better metabolic function and Qo L after surgery. 展开更多
关键词 low-grade malignant neoplasm VENTRAL PANCREAS PRESERVING SUBTOTAL PANCREATECTOMY Quality of life
下载PDF
Clinical study on the effect of abdominal cavity chemotherapy by hot perfusion and sustained low losmatic pressure on malignant ascites caused by gastrointestinal tumors
2
作者 杨光 刘长安 《中国组织工程研究与临床康复》 CAS CSCD 2001年第18期152-,共2页
关键词 Clinical study on the effect of abdominal cavity chemotherapy by hot perfusion and sustained low losmatic pressure on malignant ascites caused by gastrointestinal tumors
下载PDF
Synchronous Mucinous Borderline Tumor of the Ovary and Low-Grade Appendiceal Mucinous Neoplasm 被引量:1
3
作者 Tsutomu Muramoto Ryo Koike 《Open Journal of Obstetrics and Gynecology》 2021年第6期794-803,共10页
We present a rare case of synchronous mucinous borderline tumor of the ovary and low-grade appendiceal mucinous neoplasm (LAMN). We performed a left adnexectomy to diagnose the left ovarian borderline malignancy and a... We present a rare case of synchronous mucinous borderline tumor of the ovary and low-grade appendiceal mucinous neoplasm (LAMN). We performed a left adnexectomy to diagnose the left ovarian borderline malignancy and an ileostomy because of the swollen appendix during the operation. It was diagnosed as left ovarian mucinous borderline malignancy and LAMN. LAMN causes peritoneal dissemination, ovarian metastasis, and peritoneal pseudomyxoma. The appendix and ovary are close to each other anatomically and can metastasize if there is a tumor in either. For ovarian mucinous tumors, it is necessary to search the gastrointestinal tract, especially the appendix, as the primary lesion. For appendix tumors, it is necessary to search for the ovary. Since LAMN may be associated with borderline ovarian malignancies, as in this case, there is a possibility of the duplication of tumors when searching for ovarian mucinous tumors as the primary tumor and if ovarian tumors are found. Since LAMN and mucinous ovarian tumors have similar histological features, immunohistochemical staining is useful for their differentiation because they show different immunostaining patterns. 展开更多
关键词 low-grade Appendiceal Mucinous Neoplasm Mucinous Ovarian tumor Synchronous tumors Immunohistochemical Staining
下载PDF
A Case of Low-Grade Appendiceal Mucinous Neoplasm of Its Difficultly to Distinguish from a Right Ovarian Tumor Due to Postmenopause
4
作者 Tsutomu Muramoto Kyosuke Kamijo +3 位作者 Megumi Sano Yuki Ibuki Atushi Mori Yaeko Kobayashi 《Open Journal of Obstetrics and Gynecology》 CAS 2022年第11期1140-1146,共7页
We here present a rare case of appendiceal tumor mimicking ovarian tumor in menopause woman. The patient was a 56-year-old woman, G1P1, who presented to our hospital with a right adnexal cyst diagnosed at another hosp... We here present a rare case of appendiceal tumor mimicking ovarian tumor in menopause woman. The patient was a 56-year-old woman, G1P1, who presented to our hospital with a right adnexal cyst diagnosed at another hospital. Transvaginal echocardiography showed a cyst in the right adnexal region, and pelvic contrast-enhanced MRI revealed a small cyst in the same region. The left ovary was atrophic and identifiable. It was unclear whether the cyst was contiguous with the gastrointestinal tract. Blood tests showed no elevation of tumor markers. We considered its possibility of a gastrointestinal origin, but since right normal ovary was not found, we thought the tumor was of ovarian origin and decided on a laparoscopic resection of the right adnexa. Intraoperatively, we observed atrophied bilateral normal ovaries, and the pelvic tumor was contiguous to the appendix. Surgeons performed a laparoscopic appendectomy after consultation with us. After resection we searched the abdominal and pelvic cavities, but found no obvious disseminated lesions. The histological diagnosis was low-grade appendiceal mucinous neoplasm (LAMN), a rare benign tumor of the appendix. Appendiceal tumors can be difficult to differentiate from right ovarian tumors due to their close anatomic location in the pelvis. It is possible to determine whether the tumor is of ovarian or appendiceal origin by identifying normal ovaries and the location of the feeding vessels into the tumors. In our case, there were no lesions other than the appendix, but LAMN can metastasize to the ovary, cause pseudomyoxoma peritonei, or be an overlapping tumor with an ovarian tumor. If an appendiceal tumor is diagnosed after surgery for ovarian tumor, the intra-abdominal cavity should be searched for metastasis or dissemination, and a thorough search for ovarian lesions should be performed with the possibility of an overlapping tumor in mind. 展开更多
关键词 low-grade Appendiceal Mucinous Neoplasm Ovarian tumor Menopause Woman
下载PDF
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13) 被引量:1
5
作者 Stanislaw R. Burzynski Tomasz J. Janicki Gregory S. Burzynski 《Journal of Cancer Therapy》 2016年第12期837-850,共14页
Nonresectable Low-Grade Astrocytomas (LGA) can compromise function and threaten life. For the majority of patients, the most appropriate strategy is initial chemotherapy followed by Radiation Therapy (RT). Since curat... Nonresectable Low-Grade Astrocytomas (LGA) can compromise function and threaten life. For the majority of patients, the most appropriate strategy is initial chemotherapy followed by Radiation Therapy (RT). Since curative treatment is not available for most of these patients, it is reasonable to conduct clinical studies to evaluate new agents. This Phase II study evaluates efficacy and safety of Antineoplastons A10 and AS2-1 (ANP) in LGA. Sixteen children diagnosed with LGA were treated. They included 12 males and 4 females, ages 1.6 - 17.4 years (median 10.6). Efficacy was evaluated in 16 patients. The majority of patients were previously treated, but 1 patient had stereotactic biopsy only. Out of the remaining 15 patients, 6 patients received chemotherapy, and 7 patients had surgery, and 2 patients received RT and chemotherapy after surgery. The patients received treatment with ANP administered daily every 4 hours (median dose of A10 was 7.71 g/kg/d and AS2-1 was 0.26 g/kg/d) until objective response or stable disease was documented and for 8 months thereafter. The duration of ANP IV ranged from 1.4 to 286 weeks with a median of 83 weeks. A complete response was documented in 25.0%, partial response in 12.5%, and stable disease in 37.5%. Overall survival was 67.7% at 5 years, and 54.2% at 10 and 15 years. Progression-free survival was 48.1%, 34.4% and 34.4% at 5, 10, and 15 years respectively. The treatment was associated with grade 3 or grade 4 Adverse Drug Experiences (ADE) in 6 patients. There were two hypernatremias of grade 4 (12%). Grade 3 ADE included urinary frequency (6%), fatigue (6%) and hypernatremia (6%). There were no chronic toxicities, and there was a high quality of survival. ANP shows efficacy with a very good toxicity profile in this cohort of children with low-grade astrocytoma. 展开更多
关键词 Antineoplastons A10 and AS2-1 ASTROCYTOMA low-grade Astrocytoma low-grade Glioma Pediatric Brain tumors Phase II Clinical Trial
下载PDF
Low Grade Fibromyxoid Sarcomas and Multiple Myeloma in the Same Patient: One Case Report and Literature Review
6
作者 Chong-mei HUANG Shu-qing LU +3 位作者 Jian-min WANG Xiao-xia HU Li-li WU Jian-min YANG 《Clinical oncology and cancer researeh》 CAS CSCD 2010年第3期210-213,共4页
IntroductionMultiple myeloma (MM) is a neoplastic plasma cell dyscrasia char-acterized by anemia; a monoclonal protein(M-protein) in the serum and/or urine; abnormal bone radiographs and bone pain;hypercal-cemia; ... IntroductionMultiple myeloma (MM) is a neoplastic plasma cell dyscrasia char-acterized by anemia; a monoclonal protein(M-protein) in the serum and/or urine; abnormal bone radiographs and bone pain;hypercal-cemia; and renal insuf.ciency or failure.According to the results of immunoelectrophoresis, patients are separated to Ig type (IgG, IgA, IgD, IgE and IgM); light chain; nonsecretory. 展开更多
关键词 multiple myeloma low grade fibromyxoid sarcomas second malignancy CHEMOTHERAPY alkylating agents radiation
下载PDF
低分子肝素钙联合逐级加压弹力袜预防妇科恶性肿瘤患者术后下肢深静脉血栓的临床研究
7
作者 廖爱红 郭雪华 罗艳 《当代医学》 2024年第6期77-80,共4页
目的探讨低分子肝素钙联合逐级加压弹力袜预防妇科恶性肿瘤患者术后下肢深静脉血栓(DVT)的临床效果。方法选取2022年1—12月于赣南医学院第一附属医院经外科手术治疗的180例妇科肿瘤患者作为研究对象,按照随机数字表法分为对照组与研究... 目的探讨低分子肝素钙联合逐级加压弹力袜预防妇科恶性肿瘤患者术后下肢深静脉血栓(DVT)的临床效果。方法选取2022年1—12月于赣南医学院第一附属医院经外科手术治疗的180例妇科肿瘤患者作为研究对象,按照随机数字表法分为对照组与研究组,每组90例。对照组予低分子肝素钙进行常规治疗,研究组在对照组基础上联合逐级加压弹力袜治疗。比较两组血清学指标、凝血功能指标、血流速度、下肢周径及术后DVT发生情况。结果干预后,研究组血小板计数、纤维蛋白原、D-二聚体水平均低于对照组,差异有统计学意义(P<0.05)。干预后,研究组活化部分凝血活酶时间、凝血酶原时间、凝血酶时间均长于对照组,下肢血流峰速、血流平均速度均快于对照组,差异有统计学意义(P<0.05)。干预后,研究组下肢周径短于对照组,术后下肢DVT发生率低于对照组,差异有统计学意义(P<0.05)。结论低分子肝素钙联合逐级加压弹力袜治疗经外科手术的妇科肿瘤患者,有助于预防术后DVT形成,改善机体血流状态,值得临床推广应用。 展开更多
关键词 低分子肝素钙 逐级加压弹力袜 妇科患者 恶性肿瘤 下肢深静脉血栓
下载PDF
ARHGAP8在中低位局部进展期直肠癌新辅助化疗疗效预测中的应用
8
作者 郗宇宁 薛军 +7 位作者 武雪亮 屈明 孙光源 韩磊 郭飞 张春泽 王一飞 梁卫政 《中国医学科学院学报》 CAS CSCD 北大核心 2024年第4期528-538,共11页
目的分析ARHGAP8对中低位局部进展期直肠癌新辅助化疗疗效预测的敏感性,为进展期直肠癌的治疗提供精准依据。方法通过生物信息学分析筛选,获得差异基因ARHGAP8。选取68例原发性直肠癌患者的直肠癌组织及直肠组织标本,应用实时荧光定量PC... 目的分析ARHGAP8对中低位局部进展期直肠癌新辅助化疗疗效预测的敏感性,为进展期直肠癌的治疗提供精准依据。方法通过生物信息学分析筛选,获得差异基因ARHGAP8。选取68例原发性直肠癌患者的直肠癌组织及直肠组织标本,应用实时荧光定量PCR、Western blot和免疫组织化学方法分别对ARHGAP8的表达强度进行验证,并收集患者性别、年龄、分期、肿瘤大小、分化程度、病理类型等临床病理特征进行功能验证;选取44例行新辅助化疗的中低位局部进展期直肠癌患者,采用免疫组织化学方法检测新辅助化疗前后ARHGAP8的表达情况,分析ARHGAP8在新辅助化疗前后、不同疗效组之间的表达情况。结果生物信息学结果显示,ARHGAP8在癌组织及直肠组织中的表达差异有统计学意义(P<0.001),且ARHGAP8的表达水平与肿瘤分期(P=0.024)、淋巴结转移(P=0.007)、年龄(P=0.005)等临床特征相关。实时荧光定量PCR结果显示,ARHGAP8 mRNA在癌组织中的表达显著高于直肠组织(P<0.001);Western blot和免疫组织化学结果显示,ARHGAP8蛋白在癌组织中的表达显著高于直肠组织(P=0.011);ARHGAP8的表达与肿瘤大小(P=0.010)、病理分期(P=0.005)密切相关,而与肿瘤分化程度、淋巴结转移、肝转移、Ki-67、微卫星不稳定性的表达程度无相关性。44例接受新辅助化疗的患者中TRG 0级13例、1级8例、2级8例、3级15例,其中65.91%(29/44)的患者新辅助化疗有效,新辅助化疗有效患者治疗后ARHGAP8的表达显著下降(P<0.001),ARHGAP8蛋白低表达患者的有效率为92.86%,显著高于ARHGAP8蛋白高表达者(53.33%)(P=0.033)。结论ARHGAP8在直肠癌组织中高表达,ARHGAP8低表达的中低位局部进展期直肠癌患者对XELOX方案新辅助化疗更为敏感,ARHGAP8可作为直肠癌发生发展的潜在生物学指标,同时可作为中低位局部进展期直肠癌XELOX方案新辅助化疗疗效评估的重要参考指标。 展开更多
关键词 中低位局部进展期直肠癌 ARHGAP8 新辅助化疗 疗效评估 肿瘤退缩分级
下载PDF
低级别嗜酸性肾肿瘤3例报告并文献复习
9
作者 孙新光 宋志雪 +5 位作者 高双友 温英武 邓绍晖 郝一昌 陆敏 张树栋 《现代泌尿外科杂志》 CAS 2024年第10期912-915,共4页
目的总结3例低级别嗜酸性肾肿瘤(LOT)患者的临床信息、影像学表现、病理表现及预后,提高临床对该疾病的认识。方法回顾性分析北京大学第三医院2020年2月—2022年9月收治的3例LOT患者的临床资料、影像学表现、病理资料及术后随访情况。结... 目的总结3例低级别嗜酸性肾肿瘤(LOT)患者的临床信息、影像学表现、病理表现及预后,提高临床对该疾病的认识。方法回顾性分析北京大学第三医院2020年2月—2022年9月收治的3例LOT患者的临床资料、影像学表现、病理资料及术后随访情况。结果3例确诊为LOT的患者均为男性,年龄51~70岁,肿瘤最大径14~21 mm,均为单发。患者均无特殊临床表现,计算机断层扫描示类圆形等密度影。3例患者均行保留肾单位的肿瘤切除术。大体标本的切面为棕黄色或棕色,肿瘤呈实性或部分区域囊实性。HE染色可见细胞质呈均匀的嗜酸性,细胞核呈圆形或椭圆形,局部可能有细微的核周空晕。免疫组化示CK7(+)、CD117(-)。病例2行基因检测提示可能具有临床意义的体细胞变异1个(结节性硬化症2基因)。术后随访时间12~23个月,随访期间肿瘤均未复发。结论LOT在临床症状与影像学上无明显特征,在组织形态学上表现出与肾嗜酸细胞瘤和肾嫌色细胞癌杂合性或交界性的特征,生物学行为呈惰性表现,行保留肾单位的肿瘤切除术,患者预后良好。 展开更多
关键词 低级别 肾肿瘤 肾嗜酸细胞瘤 肾嫌色细胞癌
下载PDF
低级别嗜酸细胞性肾肿瘤5例临床病理分析
10
作者 杨倩倩 郭凌川 +3 位作者 孙思思 郭霞 杨红丽 黄仁鹏 《临床与实验病理学杂志》 CAS 北大核心 2024年第10期1058-1063,共6页
目的探讨低级别嗜酸细胞性肾肿瘤(low-grade oncocytic tumor of kidney,LOT)的临床病理特征、免疫表型、分子遗传学特征及鉴别诊断。方法收集5例LOT,采用HE、免疫组化EnVision两步法染色及Sanger测序,分析其临床病理学特征、免疫表型... 目的探讨低级别嗜酸细胞性肾肿瘤(low-grade oncocytic tumor of kidney,LOT)的临床病理特征、免疫表型、分子遗传学特征及鉴别诊断。方法收集5例LOT,采用HE、免疫组化EnVision两步法染色及Sanger测序,分析其临床病理学特征、免疫表型、分子遗传学特征、预后等,并复习相关文献。结果5例LOT中女性4例,男性1例,年龄57~70岁,中位年龄65岁,平均64.8岁。临床表现:仅例1出现尿频伴间断腰痛,其余患者无症状,为偶然发现。影像学特征:B超表现为占位性病变,边界清,内部回声均匀;CT示中心见斑片状低密度影,边缘明显强化。眼观:瘤体呈结节状,最大径2.1~7.6 cm,平均4.04 cm,切面实性。镜检:LOT界清,部分可见厚包膜,肿瘤细胞多构成致密区及稀疏区,新鲜出血灶及蛋白样分泌物常见,可见灶性淋巴细胞聚集、肝板样及肝血窦样结构、厚壁血管、胶原纤维束分割肿瘤细胞形成的假结节及陈旧性出血。肿瘤细胞温和较一致,圆形或多角形,胞质丰富嗜酸性、细颗粒状,核大小一致,圆形、卵圆形,核膜清晰,为2级小核仁,可见核周空晕、双核细胞及核皱缩,未见核分裂象。免疫表型:瘤细胞CK7均弥漫强阳性,CD117均阴性,Ki67增殖指数低。Sanger测序提示4例有mTORC1信号通路突变(3例MTOR,1例RHEB)。患者行局部或根治性肾切除,随访2~52个月,患者均存活、未见复发。结论LOT是一种低级别、嗜酸性且罕见的肾肿瘤,生物学行为惰性,目前随访结果显示局部手术完整切除即可,预后良好,需与其他嗜酸性肾肿瘤等进行鉴别。 展开更多
关键词 低级别嗜酸细胞性肾肿瘤 形态学 Sanger测序 免疫组织化学 鉴别诊断
下载PDF
非典型影像表现的眼眶孤立性纤维瘤1例
11
作者 张特 杨华胜 《中国眼耳鼻喉科杂志》 2024年第S01期38-41,共4页
59岁男性,因“右眼球突出1年余”入院。眼部检查:右眼球前突,向外上方移位,内转、下转受限,眶压T+2,结膜轻度充血,余查体阴性。影像学示右眼内下方肌锥内外可见较大的实性肿物,与视神经、内直肌、下直肌等结构紧密相连,肿物边界清楚,内... 59岁男性,因“右眼球突出1年余”入院。眼部检查:右眼球前突,向外上方移位,内转、下转受限,眶压T+2,结膜轻度充血,余查体阴性。影像学示右眼内下方肌锥内外可见较大的实性肿物,与视神经、内直肌、下直肌等结构紧密相连,肿物边界清楚,内部信号不均匀,瘤体上、下半部磁共振成像(MRI)信号表现不一致,上半部瘤体明显强化,下半部部分不强化。入院后予下睑皮肤切口入路行右眼眶肿物完整切除,病理提示孤立性纤维瘤。讨论体会:孤立性纤维瘤不完全切除易复发,部分孤立性纤维瘤有恶变倾向,甚至危及患者生命;对于影像特征不典型需要鉴别诊断,术前鉴别诊断分析、选择合适手术方式及入路对完整切除肿瘤防止肿瘤复发具有重要意义。 展开更多
关键词 孤立性纤维瘤 低度恶性肿瘤 眼眶肿瘤
下载PDF
低级别胶质瘤术后复发和恶性转化的分子标志物及其预测价值 被引量:1
12
作者 李旭朝 周诗崎 +2 位作者 冷海斌 高大宽 徐立新 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2024年第2期284-291,共8页
目的探索低级别胶质瘤(low-grade glioma,LGG)患者术后出现复发及恶性转化(malignant transformation,MT)的危险因素。方法回顾性收集2009年3月至2019年4月接受LGG切除手术及随后进行术后随访的163例患者资料。将术后未出现复发或MT的... 目的探索低级别胶质瘤(low-grade glioma,LGG)患者术后出现复发及恶性转化(malignant transformation,MT)的危险因素。方法回顾性收集2009年3月至2019年4月接受LGG切除手术及随后进行术后随访的163例患者资料。将术后未出现复发或MT的患者纳入对照组(85例),术后出现复发的患者纳入观察1组(44例),术后出现MT的患者纳入观察2组(34例)。基于3组患者的临床资料,分析患者临床特征,并运用Logistic回归模型和受试者工作特征(receiver operating characteristic,ROC)曲线探讨复发和MT的危险因素与预测价值。结果对照组和观察1组患者在术前癫痫发作、术前卡氏(Karnofsky performance status,KPS)评分和手术方式方面均有统计学差异(P<0.05)。对照组和观察2组患者在性别、术前KPS评分、肿瘤大小和手术方式方面均有统计学差异(P<0.05)。对照组和观察1组患者在异柠檬酸脱氢酶(isocitrate dehydrogenase,IDH)突变、增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)、基质金属蛋白酶9(matrix metalloproteinase-9,MMP-9)、癌—睾丸抗原OY-TES-1、OY-TES-1 mRNA、肿瘤抑制蛋白p53、鼠双微粒体2(mouse double minute 2,MDM2)、血管内皮生长因子(vascular endothelial growth factor,VEGF)、表皮生长因子受体(epidermal growth factor receptor,EGFR)均有统计学差异(P<0.05)。对照组和观察2组患者PCNA、MMP-9、癌—睾丸抗原OY-TES-1、OY-TES-1 mRNA和VEGF均有统计学差异(P<0.05)。Logistic回归分析结果显示IDH突变、MMP-9和PCNA是LGG复发的独立危险因素(P<0.05),VEGF、MMP-9和PCNA是LGG患者MT的独立危险因素(P<0.05)。PCNA、MMP-9和IDH突变对预测LGG术后复发的曲线下面积(area under curve,AUC)分别为0.744、0.790和0.799。PCNA、MMP-9和VEGF对预测LGG术后复发的AUC分别为0.729、0.750和0.900。结论IDH突变、MMP-9和PCNA是LGG复发的独立危险因素,VEGF、MMP-9和PCNA是LGG MT的独立危险因素。这些蛋白在预测LGG术后复发和MT方面具有较高的准确性,可能在LGG的生物学行为和治疗效果中起重要作用,可以作为LGG术后患者的预后评估和个体化治疗的参考指标。 展开更多
关键词 低级别胶质瘤(LGG) 术后复发 恶性转化(MT) 危险因素 临床特点分析
下载PDF
血清LAPTM4B-35及DKK1联合低剂量超声造影在肝肿瘤良恶性诊断中的应用价值
13
作者 徐鹏 于德洋 +2 位作者 董茹婷 王宁 王磊 《医学研究与战创伤救治》 CAS 北大核心 2024年第1期53-57,共5页
目的探讨溶酶体相关4次跨膜蛋白B-35(LAPTM4B-35)、Dickkopf相关蛋白1(DKK1)在肝肿瘤血清中的表达以及联合低剂量超声造影在肝肿瘤良恶性诊断中的应用价值。方法收集2021年1月至2022年8月青岛市中心医院急诊创伤外科进行治疗的160例肝... 目的探讨溶酶体相关4次跨膜蛋白B-35(LAPTM4B-35)、Dickkopf相关蛋白1(DKK1)在肝肿瘤血清中的表达以及联合低剂量超声造影在肝肿瘤良恶性诊断中的应用价值。方法收集2021年1月至2022年8月青岛市中心医院急诊创伤外科进行治疗的160例肝肿瘤患者临床资料。根据病理学结果,将患者分为良性组(n=74)和恶性组(n=86)。比较两组血清LAPTM4B-35、DKK1水平及低剂量超声造影指标;多因素Logistic回归分析肝恶性肿瘤的影响因素;ROC曲线分析血清LAPTM4B-35、DKK1联合低剂量超声造影对肝恶性肿瘤的诊断效能。结果恶性组患者血清LAPTM4B-35、DKK1表达水平均高于良性组(P<0.05)。恶性组达峰时间低于良性组(P<0.05),峰值强度显著高于良性组(P<0.05)。多因素Logistic回归分析,结果显LAPTM4B-35、DKK1、达峰时间、峰值强度是发生肝恶性肿瘤的影响因素(P<0.05)。ROC曲线显示,血清LAPTM4B-35、DKK1、低剂量超声造影联合检测诊断肝恶性肿瘤的AUC为0.960,敏感性为89.53%,特异性为91.89%,优于其各自单独预测(Z两者联合-LAPTM4B-35=5.116、Z两者联合-DKK1=4.986、Z两者联合-达峰时间=4.657、Z两者联合-峰值强度=4.214,P<0.05)。结论肝肿瘤恶性患者血清LAPTM4B-35、DKK1表达水平显著升高,联合低剂量超声造影在肝恶性肿瘤的诊断中具有较高的应用价值。 展开更多
关键词 溶酶体相关4次跨膜蛋白B-35 Dickkopf相关蛋白1 低剂量超声造影 肝肿瘤 良恶性诊断
下载PDF
半侧骨皮质切除灭活再植术对四肢低度恶性骨肿瘤的疗效分析
14
作者 马红帅 李彦华 王慧 《实用癌症杂志》 2024年第4期569-572,共4页
目的探讨半侧骨皮质切除灭活再植术对四肢低度恶性骨肿瘤的疗效。方法选取四肢低度恶性骨肿瘤108例,依照随机数字表法划分为对照组(n=54)和研究组(n=54),对照组使用人工关节置换术,研究组使用半侧骨皮质切除灭活再植术。对比2组优良率... 目的探讨半侧骨皮质切除灭活再植术对四肢低度恶性骨肿瘤的疗效。方法选取四肢低度恶性骨肿瘤108例,依照随机数字表法划分为对照组(n=54)和研究组(n=54),对照组使用人工关节置换术,研究组使用半侧骨皮质切除灭活再植术。对比2组优良率、围术期变化、日常生活功能、肢体能力、血清因子[肿瘤坏死因子-α(TNF-α)、可溶性血管粘附分子(s VCAM-1)]、并发症发生率。结果研究组优良率[96.30%(52/54)]较对照组[72.22%(39/54)]高(P<0.05);与对照组比较,研究组手术时长、住院时长短,且术中出血量少(P<0.05);与对照组比较,术后6个月研究组日常生活功能、肢体能力分值高(P<0.05);与对照组比较,术后6个月研究组TNF-α、s VCAM-1水平低(P<0.05);研究组截肢、肌肉萎缩发生率[1.85%(1/54)、7.41%(4/54)]与对照组[5.56%(3/54)、14.81%(8/54)]比较,无显著变化(P>0.05),且研究组感染发生率[0.00%(0/54)]比对照组[16.67%(9/54)]低(P<0.05)。结论半侧骨皮质切除灭活再植应用于四肢低度恶性骨肿瘤中可以提高优良率,改善围术期变化,可下调血清因子,改善日常生活功能和肢体能力,并能降低术后感染发生风险。 展开更多
关键词 四肢低度恶性骨肿瘤 半侧骨皮质切除灭活再植术 免疫能力 血清肿瘤标志物
下载PDF
利伐沙班与低分子量肝素钙治疗恶性肿瘤合并静脉血栓栓塞症的疗效对比
15
作者 田爱军 王朝霞 《中国实用医药》 2024年第20期114-117,共4页
目的对比利伐沙班与低分子量肝素钙治疗恶性肿瘤合并静脉血栓栓塞症的疗效。方法择取68例恶性肿瘤合并静脉血栓栓塞症患者,利用随机数字表分为对照组和观察组,每组34例。对照组采用低分子量肝素钙治疗,观察组实施利伐沙班治疗。对比两... 目的对比利伐沙班与低分子量肝素钙治疗恶性肿瘤合并静脉血栓栓塞症的疗效。方法择取68例恶性肿瘤合并静脉血栓栓塞症患者,利用随机数字表分为对照组和观察组,每组34例。对照组采用低分子量肝素钙治疗,观察组实施利伐沙班治疗。对比两组凝血功能指标、临床疗效及随访相关情况。结果治疗后,观察组的凝血酶时间(TT)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、D-二聚体(D-D)、纤维蛋白原(FIB)、国际标准化比值(INR)分别为(16.90±1.29)s、(12.18±1.51)s、(27.77±4.54)s、(1.08±0.30)mg/L、(3.82±0.68)g/L、INR(0.99±0.11),与对照组的(16.52±1.18)s、(12.13±1.45)s、(28.60±4.67)s、(1.12±0.33)mg/L、(3.90±0.79)g/L、INR(0.97±0.08)对比差异不大(P>0.05)。观察组总有效率为91.18%,出血事件发生率为8.82%,复发率为11.76%,死亡率为2.94%,与对照组的88.24%、11.76%、14.71%、5.88%对比差异不大(P>0.05)。结论对恶性肿瘤合并静脉血栓栓塞症患者采用利伐沙班、低分子量肝素钙治疗均可取得较好的效果且安全性相当,临床可根据患者具体情况选择用药。 展开更多
关键词 恶性肿瘤 静脉血栓栓塞症 利伐沙班 低分子量肝素钙
下载PDF
定量动态增强MRI对骨肿瘤的诊断价值分析
16
作者 戎有磊 《中国伤残医学》 2024年第11期26-29,共4页
目的:探讨与分析定量动态增强核磁共振成像(MRI)对骨肿瘤的诊断价值.方法:选取2021年4月—2023年1月我院收治的72例骨肿瘤患者中为研究对象.经病理检查证实,所有患者都给予定量动态增强MRI检查,记录成像特征.以病理检查为诊断的金标准,... 目的:探讨与分析定量动态增强核磁共振成像(MRI)对骨肿瘤的诊断价值.方法:选取2021年4月—2023年1月我院收治的72例骨肿瘤患者中为研究对象.经病理检查证实,所有患者都给予定量动态增强MRI检查,记录成像特征.以病理检查为诊断的金标准,判断定量动态增强MRI的诊断价值.结果:在72例患者中,病理诊断为良性肿瘤40例,恶性肿瘤32例,2组的性别、年龄、体重指数、骨肿瘤位置、收缩压、舒张压对比,组间差异无统计学意义(P>0.05).恶性肿瘤组的核磁共振成像骨质破坏、骨质边缘模糊、钙化、肢体受累占比分别为78.1%、93.8%、81.3%、90.6%,均高于良性肿瘤组的35.0%、47.5%、40.0%、35.0%,组间差异有统计学意义(P<0.05).恶性肿瘤组的核磁共振成像T 1WI序列、T 2WI序列低信号占比分别为78.1%、81.3%,均高于良性肿瘤组的47.5%、50.0%,组间差异有统计学意义(P<0.05).恶性肿瘤组的定量动态增强核磁共振成像参数-血管外细胞外间隙容积分数、容量转运常数、速率常数均高于良性肿瘤组,组间差异有统计学意义(P<0.05).在72例患者中,定量动态增强MRI判断为恶性肿瘤31例,良性肿瘤41例,定量动态增强MRI对骨肿瘤良恶性的鉴别诊断敏感性与特异性分别为96.7%、92.9%.结论:恶性骨肿瘤患者在核磁共振成像中多伴随有骨功能下降,且多呈现低信号,伴随有定量动态增强参数的异常,定量动态增强MRI对骨肿瘤良恶性的鉴别诊断敏感性与特异性都比较高. 展开更多
关键词 恶性骨肿瘤 核磁共振成像 定量动态增强参数 低信号 骨质边缘模糊 敏感性
下载PDF
低频脉冲治疗对老年晚期恶性肿瘤化疗后骨髓抑制的有效性探讨
17
作者 李海燕 陈湘燕 王娟 《系统医学》 2024年第4期162-164,168,共4页
目的 探究低频脉冲治疗对老年晚期恶性肿瘤化疗后骨髓抑制的有效性。方法 选取泰州市姜堰中医院肿瘤科于2020年1月—2022年12月收治的60例老年晚期恶性肿瘤化疗后骨髓抑制患者为研究对象,按照随机抽签法分为对照组(予以常规对症治疗)、... 目的 探究低频脉冲治疗对老年晚期恶性肿瘤化疗后骨髓抑制的有效性。方法 选取泰州市姜堰中医院肿瘤科于2020年1月—2022年12月收治的60例老年晚期恶性肿瘤化疗后骨髓抑制患者为研究对象,按照随机抽签法分为对照组(予以常规对症治疗)、观察组(在常规对症治疗基础上辅以低频脉冲治疗),各30例。对比两组骨髓抑制严重程度、健康状况、生活质量,所用工具为卡氏评分(Karnofsky Performance Score,KPS)、癌症患者生命质量测定量表(Functional Assessment of Cancer Therapy,FACT-G)。结果 治疗后,观察组骨髓抑制程度优于对照组,差异有统计学意义(Z=-2.023,P<0.05)。治疗后,观察组KPS评分为(89.21±5.11)分,FACT-G评分为(88.23±6.11)分,高于对照组的(77.71±4.33)分、(75.61±5.31)分,差异有统计学意义(t=9.404、8.539,P均<0.05)。结论 低频脉冲治疗的辅助价值更高,可有效减轻患者病情严重程度,提高机体健康水平,改善生活质量。 展开更多
关键词 老年 晚期恶性肿瘤化疗后骨髓抑制 低频脉冲治疗 经皮穴位电刺激 效果观察
下载PDF
A Case of Diagnosis of Pseudomyxoma Peritonei
18
作者 Yanfei Wang Can Liu 《Yangtze Medicine》 2024年第3期72-81,共10页
Objective: To report a case of pseudomyxoma peritonei accidentally discovered during preoperative examination and review relevant literature to improve the early diagnosis of the origin of pseudomyxoma peritonei. Meth... Objective: To report a case of pseudomyxoma peritonei accidentally discovered during preoperative examination and review relevant literature to improve the early diagnosis of the origin of pseudomyxoma peritonei. Methods: To analyze a case accidentally discovered due to abdominal distension in our hospital in October 2023. Combined with domestic and foreign literature, the etiology, clinical manifestations, diagnosis, differential diagnosis and treatment of PMP were discussed. Results: The patient was admitted due to abdominal distension with no other specific discomfort. Mucinous tumors were found during imaging examinations. Conclusion: PMP is a rare disease, and clinical manifestations often include abdominal distension. It is usually first discovered through imaging examinations such as ultrasound, CT or MRI. CRS and HIPEC are still recommended as the standard treatment for PMP. 展开更多
关键词 Pseudomyxoma Peritonei low-grade Mucinous tumor
下载PDF
Epilepsy associated tumors: Review article 被引量:9
19
作者 Marco Giulioni Gianluca Marucci +11 位作者 Matteo Martinoni Anna Federica Marliani Francesco Toni Fiorina Bartiromo Lilia Volpi Patrizia Riguzzi Francesca Bisulli Ilaria Naldi Roberto Michelucci Agostino Baruzzi Paolo Tinuper Guido Rubboli 《World Journal of Clinical Cases》 SCIE 2014年第11期623-641,共19页
Long-term epilepsy associated tumors(LEAT) represent a well known cause of focal epilepsies. Glioneuronaltumors are the most frequent histological type consisting of a mixture of glial and neuronal elements and most c... Long-term epilepsy associated tumors(LEAT) represent a well known cause of focal epilepsies. Glioneuronaltumors are the most frequent histological type consisting of a mixture of glial and neuronal elements and most commonly ariseing in the temporal lobe. Cortical dysplasia or other neuronal migration abnormalities often coexist. Epilepsy associated with LEAT is generally poorly controlled by antiepileptic drugs while, on the other hand, it is high responsive to surgical treatment. However the best management strategy of tumor-related focal epilepsies remains controversial representing a contemporary issues in epilepsy surgery. Temporo-mesial LEAT have a widespread epileptic networkwith complex epileptogenic mechanisms. By using an epilepsy surgery oriented strategy LEAT may have an excellent seizure outcome therefore surgical treatment should be offered early, irrespective of pharmacoresistance, avoiding both the consequences of uncontrolled seizures as well as the side effects of prolonged pharmacological therapy and the rare risk of malignant transformation. 展开更多
关键词 EPILEPSY low grade tumorS Long-term EPILEPSY ASSOCIATED tumorS Glioneuronal tumorS GANGLIOGLIOMA Dysembryoplastic NEUROEPITHELIAL tumor LESIONECTOMY EPILEPSY surgery
下载PDF
A CLINICAL ANALYSIS OF 38 PATIENTS WITH PRIMARY TRACHEO BRONCHIAL TUMORS 被引量:1
20
作者 任华 柏刚 +3 位作者 李泽坚 张志庸 孙成孚 徐乐天 《Chinese Medical Sciences Journal》 CAS CSCD 1994年第4期263-265,共3页
During a 17-year period, 38 patients with primary tracheobronchial tumors received surgical treatment in PUMC Hospital. Arnong the 38. 12 had low-malignancy tracheal tumors, 11 had benign tracheal tumors, 14 had low m... During a 17-year period, 38 patients with primary tracheobronchial tumors received surgical treatment in PUMC Hospital. Arnong the 38. 12 had low-malignancy tracheal tumors, 11 had benign tracheal tumors, 14 had low malignancy bronchial tumors and 1 had a benign bronchial tumor. Fifteen operations were perforrned on 12 patients with low-malignancy tracheal tumors, including local resection of the tumor and tracheal wall in 4 and curettage of the tumor plus electrical cauterization in 10. Postoperative radiotherapy was used as an adjuvant treatment in 8 patients with adenocystic carcinoma. Eight patients have survived for more than 5 years and 3 patients have survived for longer than 10 years postoperatively. All 11 patients with benign tumors received curettage of the tumor and were followed up for an average of 6. 5 years. Among them, 9 are still alive. Of the 14 patients with low malignancy bronchial tumors, 5 underwent curettage of the tumor plus electrical cauterization through incision of the main bronchus or intermedial bronchus, and 7 underwent lobectomy or pneumonectomy. The authors conclude that the correct diagnosis rate can be increased by enhancing recognition of this disease and applying tracheal tomography and bronchoscopy. 展开更多
关键词 tracheobronchial tumors low malignancy MISDIAGNOSIS
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部